Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

Epstein sees a clear direction of travel in private markets. “The trend line is toward standardized data and repeatable ...

The plain, though somewhat striking, reality is that Advanced Micro Devices’ ($AMD) share price has more than doubled this ...

Leidos shows Q3 beats, strong growth, a $69B backlog, rising guidance and continued returns with solid demand and valuation ...

Q4 2025 Earnings Call Transcript November 13, 2025 MarineMax, Inc. beats earnings expectations. Reported EPS is $-0.03978, ...

ObesityWeek 2025, held in Atlanta from November 4-7, showcased unprecedented clinical data that signals a fundamental shift in the obesity treatment landscape. The most striking breakthrough at ...

NVIDIA, Micron Technology and Thermo Fisher lead today's top analyst picks, each showing strong growth trends and strategic advances.

Given the GOP’s sturdy 53-seat majority in the Senate, combined with the increasing rarity of split-ticket voters, the ...

I find this interview that Steve Eisman did with Evercore ISI's Glenn Schorr to be illuminating. The Private Credit Panic. The most personally illuminating thing was the ROE difference between a trad ...

That security slump was highlighted by a 2% drop in segment revenues during the first quarter of Cisco’s fiscal 2026 compared to the same quarter last year. CEO Chuck Robbins tied the drop to a faster ...

The private company that promised to be “financially viable on its own” is losing money — and using government subsidies to ...

Produced Higher Margins, Lower Operating Expenses, and Significantly Narrowed Losses Compared to Q2 2025New Product Introductions and Sales ...